IIM
NRIX icon

INTECH Investment Management’s Nurix Therapeutics NRIX Stock Holding History

INTECH Investment Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$354K Sell
22,813
-2,202
-9% -$36.5K ﹤0.01% 1496
2025
Q4 		$475K Sell
25,015
-8,264
-25% -$119K ﹤0.01% 1534
2025
Q3 		$307K Sell
33,279
-9,074
-21% -$94.2K ﹤0.01% 1814
2025
Q2 		$482K Sell
42,353
-14,417
-25% -$156K ﹤0.01% 1624
2025
Q1 		$674K Buy
56,770
+20,934
+58% +$350K 0.01% 1449
2024
Q4 		$675K Buy
35,836
+16,935
+90% +$388K 0.01% 1384
2024
Q3 		$425K Buy
+18,901
New +$428K ﹤0.01% 1317

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

INTECH Investment Management's NRIX Position: Q1 2026 in Review

INTECH Investment Management reduced its Nurix Therapeutics (NRIX) stake by 8.8% in Q1 2026, selling an estimated $36.5K and leaving 22,813 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

INTECH Investment Management first reported a position in NRIX in Q3 2024 and has held it in 7 quarters since. The position peaked at $675K in Q4 2024. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • INTECH Investment Management held 22,813 shares of Nurix Therapeutics worth $354K as of Q1 2026.
  • INTECH Investment Management sold 2,202 Nurix Therapeutics shares in Q1 2026, an estimated $36.5K.
  • Nurix Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1496 holding.
  • INTECH Investment Management first reported a position in Nurix Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Nurix Therapeutics position peaked at $675K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.